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RESUMEN 
 
 
Un problema que amenaza la salud humana hoy en día es el desarrollo de bacterias 
multiresistentes o “súper-bacterias”, las cuales se pueden encontrar en el tracto gastrointestinal 
de animales y humanos como microbiota comensal. El uso de antimicrobianos en la crianza de 
animales es difícil de controlar y contribuye al incremento de resistencia a antibióticos en 
humanos. Hoy en día está demostrado que la interacción entre animales y humanos lleva a éstos 
a compartir parte de su microbiota y en ella diferentes genes de resistencia que son pasados a 
través de los elementos genéticos móviles (MGE).  Nosotros investigamos la presencia de genes 
de resistencia encontrados en bacterias comensales intestinales de animales y humanos de las 
cuales se obtuvo 56 cepas de Escherichia coli comensal de humanos y animales domésticos  las 
mismas que fueron sometidas a antibiograma, análisis genético (genes cromosómicos y 
plasmídicos). De las 56 cepas, 44 fueron de  humanos y 12 de animales. El patrón de resistencia 
antibiótica incluyó: tetraciclina (58,9%), cefalotina (55,4%), sulfisoxazol y ampicilina (46,4%) y 
trimetoprim/sulfametoxazol (39,3%). Se obtuvo  18 transconjugados cuyos replicones fueron FII y 
FIB en aislados de humanos y FII y X2 en aislados de animales domésticos. Los replicones más 
comunes en 8 cepas seleccionadas (de animales y humanos) fueron FII18, FIA6, y FIB1. 
Mientras que los variantes alélicos  de resistencia a antibióticos encontrados en aislados de 
humanos y animales fueron: blaTEM-1B, qnrB19, mph(A), sul2 y fosA. 
 
 Palabras clave: Escherichia coli, humanos, animales, Transferencia horizontal de genes, 
elementos genéticos móviles, genes de resistencia, plásmidos. 
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ABSTRACT 
 
A problem that threatens human health today is the development of multiresistant 
bacteria or "super-bacteria", which can be found in the gastrointestinal tract of animals and 
humans as a commensal microbiota. The use of antimicrobials in animal husbandry is difficult to 
control and leads to an increase in antibiotic resistance. Nowadays it is demonstrated that the 
interaction between animals and humans leads them to share part of their microbiota and 
different resistance genes that are passed through the mobile genetic elements (MGE). We 
investigated the presence of resistance genes found in commensal intestinal microbiota of 
animals and humans from which 56 strains of commensal Escherichia coli were obtained and 
were subjected to antibiogram and genetic analysis (chromosomal and plasmid genes). From the 
56 strains, 44 were from humans and 12 from animals. The antibiotic resistance pattern included: 
tetracycline (58.9%), cephalothin (55.4%), sulfisoxazole and ampicillin (46.4%) and trimethoprim / 
sulfamethoxazole (39.3%). We obtained 18 transconjugates whose replicons were FII and FIB in 
human isolates and FII and X2 in isolates of domestic animals. While the allelic variants of 
antibiotic resistance genes present in humans and domestic animals were: blaTEM-1B, qnrB19, 
mph (A), sul2 and fosA. 
 
Key words: Escherichia coli, humans, animals, horizontal gene transfer, mobile genetic 
elements (MGE), resistance genes, plasmids. 
 
 
 
7 
 
CONTENT 
RESUMEN ..................................................................................................................................... 5 
ABSTRACT…………………………………………………………………………………………………6 
INTRODUCTION ......................................................................................................................... 11 
The Impact of Antibiotic Resistance in Human Medicine ................................................... 11 
OBJECTIVE ................................................................................................................................ 19 
MATERIALS AND METHODS .................................................................................................... 20 
RESULTS .................................................................................................................................... 24 
Antibiotic resistance profiles ................................................................................................ 24 
Isolated Genotyping ................................................................................................................. 25 
Plasmid Genotyping ................................................................................................................. 25 
Analysis of Antibiotic resistance genes .................................................................................... 26 
Plasmid and Antibiotic resistance profile .................................................................................. 26 
Antibiotic resistance in humans and animals ........................................................................... 27 
DISCUSSION............................................................................................................................... 28 
BIBLIOGRAPHY ......................................................................................................................... 30 
8 
 
ÍNDICE DE TABLAS 
 
Table 1. Antibiotic Resistance prevalence in the population .................................................... 37 
Table 2. Antibiotic resistance in humans and animals from Yaruqui Centro ............................ 37 
Table 3. Replicon typing of 18 transconjugants, 16 from Humans and 2 from Animals ........... 38 
Table 4. pMLST of the sequenced strains ............................................................................... 39 
Table 5. Resistance genes in humans and animals ................................................................ 40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 
 
ÍNDICE DE FIGURAS 
 
Figure 1. Venn´s Diagram: Replicon typing in strains of humans and animals ........................ 42 
Figure 2. Venn´s Diagram: pMLST found in strains of humans and animals ........................... 42 
Figure 3. Venn´s Diagram: gene resistance in strains of humans and animals ........................ 43 
Figure 4. Phylogenetic tree (Maximum Likelyhood) of the gene strA found in 3 different strains
 ................................................................................................................................................. 43 
Figure 5. Phylogenetic tree (Maximum Likelyhood) of the gene blaTEM-1B found in 7 different 
strains ...................................................................................................................................... 44 
Figure 6. Phylogenetic tree (Maximum Likelyhood) of the gene dfrA17 found in 4 different 
strains ...................................................................................................................................... 44 
Figure 7. Phylogenetic tree (Maximum Likelyhood) of the gene strB found in 4 different strains
 ................................................................................................................................................. 44 
Figure 8. Phylogenetic tree (Maximum Likelyhood) of the gene sul2 found in 5 different strains
 ................................................................................................................................................. 45 
Figure 9. Phylogenetic tree (Maximum Likelyhood) of the gene QnrB19 found in 5 different 
strains ...................................................................................................................................... 45
10 
 
ÍNDICE DE ANEXOS 
 
ANNEXES .................................................................................................................................... 46 
Appendix 1. Recompilation of the information of the study ...................................................... 47 
 
 
11 
 
INTRODUCTION 
 
The Impact of Antibiotic Resistance in Human Medicine  
 
The first WHO global reports on the impact of antibiotic resistance in human medicine reveals  
that this serious threat is no longer a forecast for the future but a reality in all regions of the world 
affecting anyone of any age in any country. In the absence of urgent and coordinated actions by 
many stakeholders, the world is heading for a post-antibiotic era in which common infections and 
minor injuries that have been treatable for decades will once again be life-threatening (Thomas, 
2014). 
Antibiotic resistance has an important impact in mortality and costs are estimated by many health 
authorities and scientists around the world like the Center for Disease Control and Prevention 
(CDC) who estimated that in United States each year more than two million people have 
antibiotic-resistant infections. It results in numerous deaths (about 23, 000 people), being the cost 
of these infections over $55 billion per year (which represent costs for direct healthcare $20 billion 
and society costs for lost productivity $35 billion). Similarly in Europe the number of deaths was 
around 25,000 people, and the cost around this health problem was estimated to be over 1.5 
billion euros. The bacteria most frequently found in such cases were: Staphylococcus aureus, 
Streptococcus pneumoniae, Enterococcus faecium, Escherichia coli, Klebsiella 
pneumoniae and Pseudomonas aeruginosa with the most frequent multidrug-resistant pattern 
(Prestinaci, et al., 2015). 
In Ecuador, there was a report of a Colistin resistance antibiotic gen mcr-1, which was the first 
clinical isolate of Escherichia coli (ST-609) from a male teenager with appendicitis which 
harboured mcr-1 and blaCTX-M-55 genes, the presence of commensal E. coli with the gene mcr-
1 is an alert to the presence of antibiotic resistance genes in the region, most supported by the 
idea of been a resistance of the last line of drugs which are available for several treatment in 
Gram negative bacteria with multi drug resistant patterns. (Ortega-Paredes, Barba, & Zurita, 
2016) 
The cost of the antibiotic resistance over the economy is difficult to determine, because there are 
several factors that must be taken to provide a real account like: direct healthcare cost, society 
cost (deaths and loss of productivity), antibiotics cost (third-line drugs are more expensive), use 
of specialized equipment for treatment, large periods of hospitalization and treatments that needs 
isolation (Prestinaci, et al., 2015).  
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Role of antibiotic resistance in domestic animals 
 
An important factor which threatens human health is the increasing number of resistant strains to 
antibiotics and the transmission of resistance genes between humans and animal bacteria. The 
use and misuse of antimicrobial drugs for treatment and animal husbandry is partially responsible 
for the antibiotic resistance crisis (Ranjbar & Sami, 2017). 
 
Improvement in animal growth with the help of antibiotics was described in 1940s (Moore, et al., 
1946)  and years later the addition of growth promoting antibiotics (GPAs) became very common 
(Graham, et al., 2007). In 2007, researchers compared chickens growth with and without 
antibiotics on their diet, making a summary of the economical effects of removing GPAs from 
broiler feed (Graham, et al., 2007). The indiscriminate use of antibiotics in animals is due to 
permissive legislation for antibiotic commercialization, low responsibility of professionals  and lack 
of knowledge of many people raising food animals (Ramírez, 2009). Poultry production is 
expanding in developed nations with thousands of birds raised in limited spaces and feed with 
antibiotics to prevent infections or as growth promotors. In this setings it is found a  higher 
frequency of antimicrobial resistance compared with birds who are not exposed to antibiotics 
(Moser, et al., 2017). Many people are in close contact with domesticated animals (and animal 
waste) and there is evidence that the microbiota from animals and humans could be shared, 
creating the opportunity for antibiotic resistance transfer between species (Guard, et al., 2017).   
 
Escherichia coli and the gut microbiota of humans and animals  
 
Most of people think that in a fetus the gut is sterile, however around 2011, Indira Mysorekar and 
colleagues started questioning this idea; with a study of placental tissues samples collected from 
women giving birth at Barnes-Jewish Hospital, specimens were visualized under microscope, and 
found bacteria in nearly one-third of them (Cao, Colin Macones, & Mysorekar, 2016). Latetly after 
birth bacteria such as Enterobacteriaceae and Bifidobacteriaceae invade the intestine and its 
composition thereafter depends on the diet (breast feed or formula), environment, microbiota of 
the other members of the household, etc (Mountzouris, et al., 2002). Commensal bacteria found 
in the gut belong to two important groups, the anaerobic genera  like Bifidobacterium, Clostridium, 
Bacteroides, Eubacterium (the majority) and the aerobic genera like  Escherichia, Enterococcus, 
Streptococcus, Klebsiella   (O'Hara & Shanahan, 2006 ). 
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In a study of microbial diversity of intestinal microbiota in human infants, it is shown that it trends 
for its nutritional modulation, the evolutionary and phylogenetic relationships between 
microorganisms, which in turn confers protection against several infections and diseases. There 
is evidence of the influence of nutrition and the indigenous microbiota over immune response and 
host defense (Mountzouris, et al., 2002). 
Culture-based studies have provided limited knowledge about human gut composition, but 
nowadays, high throughput sequencing and molecular phylogenetic has created a better and 
more detailed inventory of human microbiota (Chow, et al., 2010). For instance, culture 
independent studies allowed to detect changes in the taxonomic composition of the microbiota of 
preterm infants due to hospitalization, artificial ventilation, nutrition, or antibiotic treatment (Drell, 
et al., 2014). Gut microbiota from animals could be modified due to diet, age, genetic background, 
shared microbiota from the mother and also exposure to antibiotics during their life and also there 
are found Escherichia coli in most of the isolates (Mosites, et al., 2017).  
Escherichia coli have been divided into four phylogenetic groups: A, B1, B2 and D (Clermont, et 
al., 2000 ). E. coli is a facultative anaerobic, non-sporulating gram negative rod member of the 
Enterobacteriaceae family, which grows in the intestine of humans and other warm blooded 
animals (Conway & Cohen, 2015).  
In epidemiologic studies of bacterial infections is recognized that an individual may be colonized 
with more than one distinct Escherichia coli strain at any moment and time (Lautenbach, et al., 
2008). Successful colonization of an E. coli clone depends primarily on its ability to compete for 
nutrients in the lumen of the intestine where will be eliminated by the feces and the cycle will 
begin again this process is called: "The circle of colonization” and “the extra-intestinal survival”, 
this circle occurs equally in commensal and pathogenic E. coli (Conway & Cohen, 2015). 
In the stomach of humans and animals E. coli is exposed to acid, and then it reaches the colon 
where is thought to multiply logarithmically (Conway & Cohen, 2015). The mucus secreted by the 
intestine cells of animals and humans brings nutrients to E. coli niche; E. coli has adapted to use 
sugars like gluconate and other polysaccharides found in the host; the strains that colonize during 
infancy, are originated from the contamination with the feces of the mother in the moment of labor 
or from the manipulations from the staff of the hospital (Tenaillon, et al., 2010).  Non-pathogenic 
Escherichia coli normally found in the host’s gut is considered commensal bacteria as they are 
part of the normal intestinal microbiota in both humans and warm-blooded animals; the host and 
the bacteria benefit from this interaction, in one case protecting against pathogen colonization 
and on the other case suppling of nutrients necessary to grow and disseminate (Picard, et al., 
1999). 
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Intestinal infection occurs when a virulent clone introduced to the intestine and surpasses the 
defense barrier formed by commensal bacteria (Picard, et al., 1999). Natural selection is involved 
in the structure and composition of the microbiota; bacterial density increases or decreases 
depending on the surrounding environment like stomach, bile or pancreatic acids reaching about 
an amount estimated of 1011 – 1012 UFC/ml of bacteria in the colon, 105 – 106 UFC/ml in 
jejunum/ileum, 103 – 104 UFC/ml in the stomach and duodenum (Tlaskalová-Hogenová, et al., 
2011). 
Escherichia coli as well as other bacteria have a fast mechanism of replication (division occurs 
every 30 minutes) producing large populations of Gram negative rods where we could find a 
mutant cell which is rare and altered by a specific process. During the process of DNA replication 
alterations on the nucleotide sequence could occur which are called “mutations”; these errors or 
mutations could benefit,  in most cases could be slightly detrimental or in some cases  could 
disrupt the sequence code of a protein causing deleterious effects, loss of competitiveness or 
even  death (Alberts, et al., 2002). Escherichia coli genome evolution requires these errors, 
however some genes coding for optimized proteins are highly conserved which means that they 
are not easy to be changed or altered, as an example is the 16S ribosomal RNA subunit (Alberts, 
et al., 2002). 
 
Genetic information of Escherichia coli and mechanism of horizontal gene 
transfer. 
 
Due to its  wide spread disemination, Escherichia coli  is an important bacteria in terms of 
antibiotic resistance (Carlet, 2012 ). Genomic information in bacteria can change or innovate 
which are: mutation, duplication of genes, segment shuffling, horizontal transfer (Alberts, et al., 
2002). 
The mechanisms for horizontal acquisition of resistance are: conjugation, transduction and 
natural transformation (Tenaillon, et al., 2010). During conjugation, a donor bacterium connects a 
transient pilus to a recipient and transfers plasmids, integrative and conjugative elements, or also 
chromosomal DNA (in high recombination frequency strains) (Konraimann & Wagner, 2014). 
Conjugation requires cell to cell contact where the ssDNA is transported from a donor to a 
recipient cell and depends on a machinery of transfer called type IV secretion systems (T4SS) 
and additional proteins which mobilized plasmids or genomic islands; in E. coli ssDNA which is 
generated in the donor cell starts to separate from the dsDNA strand at the termed site oriT also 
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called origin of transfer (Konraimann & Wagner, 2014). At this stage, DNA transfer complex (Dtr) 
is composed by a relaxase/helicase and auxiliary proteins and is usually docked and interacts 
with the proteins of the T4SS system. This T4SS complex has ATPases, translocase proteins, 
core proteins and pilus proteins and adhesins. To start with the translocation of the ssDNA a 
mating between two bacteria has to happen, which includes initial contact with the pilus, F 
conjugation with the retraction of the pilus and finally the formation of contact zones. For a 
successful gene transfer, tra genes which are composed by Dtr and T4SS proteins are in charge 
of turning on the system at a specific moment, positive feedback which involves de Dtr complex 
and the assembly of T4SS apparatus. And finally the stimuli will turn off, when the tra genes are 
switched off as the negative feedback (Konraimann & Wagner, 2014). Some plasmids encode 
mechanisms which destroy the progeny which have not received the plasmid (toxin-anti-toxin 
systems). Plasmids have the ability to retain resistance genes and transfer them to different 
strains (Carattoli A., 2009).  
In transduction, phages (or bacterial viruses) are the carriers of transducing DNA between 
bacteria. In generalized transduction, phages can take bacterial DNA incorporating accidentally 
random pieces of the bacteria genome inside the phage. In specialized transduction the phage 
takes up accidentally the DNA of the bacteria which is near the integration site (Carlet, 2012 ). 
Transformation is as mechanism in which foreign DNA from an external source is introduced in 
other bacteria making the conversion of one genotype into another; it was first discovered in 1928 
by Frederik Griffith in Streptococcus pneumoniae giving the elucidation of molecular nature of the 
genes. The principle of transformation starts with an exogenous DNA which will be incorporated 
into another bacterial chromosome by a mechanism called “breakage-and-insertion” similar to Hfr 
× F− crosses of conjugation, but with the difference that in conjugation DNA is transferred 
through close contact, while, in transformation, isolated pieces of exogenous DNA are taken up 
by a cell not in close contact necessary. Transformation with plasmids is important because 
bacteria are used for both storing and replicating plasmids (Griffiths, et al., 2000). 
The transposable elements or transposons which are jumping short sections of DNA that move 
within the genome creating a cut and paste mechanism in which they could insert new and 
foreign DNA into virus of plasmids (Muñoz López & García Pérez, 2010).  
 
Antibiotics and resistance genes 
 
For the past years, antibiotics have been used for the treatment or prevention of infections in 
humans and animals. The first antimicrobial discovered by Fleming in 1929 was penicillin an 
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active β-lactam which binds to the penicillin binding proteins or PBPs to inhibit the synthesis of 
peptidoglycan. β-Lactams as bactericide presents low toxicity for humans or animals and slow 
time action; despite of the fact, is the treatment of choice in many infections because this 
antibiotic interferes with the cross link structure of peptidoglycan avoiding transpeptidation which 
make the lysis of the cytoplasm or increase the osmotic pressure (Suárez & Gudiol, 2009). 
Other antibiotics are sulfonamides which inhibit the synthesis of folic acid; aminoglycosides which 
inhibit protein synthesis; quinolones and rifampicin which interact with the synthesis of DNA and 
RNA respectively, etc (Van Hoek, et al., 2011). Sulfonamides are synthetic drugs which in 
combination with trimethoprim make this drug synergetic to bactericidal effects, inhibiting 2  
enzymes dihydropteroate synthase and dihydrofolate reductase respectivelly (Van Hoek, et al., 
2011). 
Aminoglycosides are bactericide antibiotics produced by soil Actinobacteria such as 
Streptomyces and Micromonospora; they are very active against Enterobacteriaceae, with a rapid 
killing action (Vakulenko & Mobashery, 2003). Streptomycin was isolated from Streptomyces 
griseus, is an aminocyclitol aminoglycoside which inhibits bacterial growth by intercating with the 
30S small ribosomal subunit resulting in bacterial dead (Kikuvi, et al., 2007). 
Chloramphenicol was obtained from Streptomyces venezuelae, is a potent inhibitor of the 
synthesis of proteins with affinity to peptidyltransferasa of 50S subunit of the 70S ribosomal RNA 
and prevents the elongation of the peptide’s chain. Quinolones and flouroquinolones  inhibit DNA 
gyrases (GyrA and GyrB subunits), and the topoisomerase IV (encoded by the genes parC and 
parE ) (Kikuvi, et al., 2007). 
Fosfomycin was isolated from different Streptomyces species, is a broad spectrum antibiotic for 
gram negative and positive bacteria; derived from phosphonic acid which inhibit the cell wall 
synthesis and permeability of bacteria (Alrowais, et al., 2015). Tetracycline was isolated from 
Streptomyces aureofaciens, is a broad spectrum antibiotic which inhibit microbial growth by 
interacting with the ribosomes interfering with the synthesis of the proteins, also depends on 
efflux pumps or enzime inactivation (Chopra & Roberts, 2001). 
Intrinsic antibiotic resistance is caused by physicochemical characteristics in the bacteria which 
are no subject natural selection; these mechanisms include: exclusion of drug molecules by 
constraints of the envelope of the bacteria, generally by the outer membrane, the 
lipopolysaccharide and porin constituents. For instance, glycopeptides are large molecules which 
cannot penetrate the outer membrane of Gram negatives or do not affect Mycoplasma which 
does not have peptidoglycan (Brown & Wright, 2016); Enterococci species are intrinsically 
resistant to cephalosporins because the drug binds to peptidoglycan binding protein PBP that this 
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bacterium lacks, Klebsiella species intrinsically resist to ampicillin because of its production of 
beta-lactamases that could destroy the drug before it reaches the PBP targets (Wolf, 2017). 
Bacterial mechanisms of resistance are caused by  lack of  penetration, efflux pumps, enzyme 
inactivation by antibiotic degradation or antibiotic modification (acetylation, adenylation, 
glucosylation and phosphorylation), target modification (i.e. methylation of ribosomal RNA), target 
mutations or deletion, target overproduction by increased transcription or multiplication of the 
genes and drug sequestration by specific biding proteins (Rhodes & Schweizer, 2016).  
In 1940, the first bacterial enzyme that could destroy penicillin was discovered by Abraham and 
Chain; the enzyme was AmpC β-lactamase (gene blaCMY) found in E. coli.  Currrently the most 
common mechanism of antimicrobial resistance to β-lactam antibiotics are β-lactamases (blaTEM-
1, blaTEM-2, and blaSHV-1). Evolution due to antibiotic pressure has resulted in extended spectrum 
β-lactamases (ESBLs) which can hydrolyze a wide range for β-lactam antibiotics (Suárez & 
Gudiol, 2009) (Van Hoek, et al., 2011). 
 
Some aminoglycoside’s resistance genes cause ribosomal alterations like: armA (aminoglycoside 
resistance methylase) gene, is a “novel plasmid-borne 16S rRNA methyltransferase” that confers 
high-level of resistance to 4,6-disubstituted deoxystreptamines and fortimicin including the 
antibiotics: gentamicin, arbekacin, amikacin, kanamycin and tobramycin, and could be transferred 
between E. coli by conjugation (González-Zorn, et al., 2005); initially found in Klebsiella 
pneumoniae, detected in many isolated bacteria like: E. coli, Citrobacter freundii, Enterobacter 
cloacae, Salmonella enterica, Shigella flexneri associated with bla(CTX-M-3) on the plasmid 
IncL/M which confers the extended-spectrum beta-lactamase resistance (Galimand, et al., 2005), 
armA gene has spread in bacteria of diverse origin, present in human and animal isolates within a 
novel transposon composite and encodes a protein similar to 16S rRNA methylases found in 
actinomycetes which produce aminoglycosides (González-Zorn, et al., 2005). other genes modify 
the aminoglycosides and they are classified according to the mechanism of antibiotic 
modification, the enzymes  are classified in: ACC Acetyltransferases (AAC(1), AAC(2’), AAC(3) 
and AAC(6’)); ANT Adenyltransferases (ANT(2″), ANT(3″), ANT(4′), ANT(6), and ANT(9)); and 
APH Phosphotransferases (APH(2″), APH(3′), APH(3″), APH(4), APH(6), APH(7″), and APH(9)) 
each one with their specific gene for example aac(1) (Vakulenko & Mobashery, 2003).  
Mutations in the rpsL gene which encode a polypeptide S12 generate resistance to streptomycin, 
Enterobacteriacea as a result of a transposition with the transposon Tn5393 found in plasmids 
(Pezzella, et al., 2004) (Springer, et al., 2001).  
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Resistance to chloramphenicol occurs also by modification of the antibiotic molecule; an 
acetyltransferase or CATs which is coded by the genes catA and catB. (Kikuvi, et al., 2007) Other 
genes involved in chloramphenicol resistance encode efflux pumps systems, such as cmlA and 
floR (Kikuvi, et al., 2007) (Van Hoek, et al., 2011). 
Resistance to quinolones  occurs by mutation in these  chromosomal genes encoding the A and 
B subunits of the protein targets: gyrA, gyrB, parC and parE (Fàbrega, et al., 2009). Plasmid 
genes also confer parcial resistance to quinolones: qnrA , qnrB , qnrC , qnrD , and qnrS, which 
encodes a pentapeptide and blocks the action of quinolones over DNA gyrase and 
topoisomerase IV (Jacoby, 2005) (Van Hoek, et al., 2011).   
Resistance to sulfonamides could be coded by genes sul1, sul2, sul3; they are carried in class 1 
integrons which are carried by plasmids (Sköld, 2000) (Van Hoek, et al., 2011). Resistance genes 
for trimethoprim are dfrA,dfrB, dfrK and dfrA27 and the newest reported DHFR gene which 
inhibits the enzyme dihydrofolate reductase among Gram negatives (Huovinen, et al., 1995) (Van 
Hoek, et al., 2011). 
Resistance to Tetracycline, is coded by twenty nine different tetracycline resistance genes or 
called “tet” genes and three oxytetracycline resistance or “otr” genes with no inherent difference 
between them. All the tet efflux genes found in Gram positive and Gram negative bacteria, code 
for membrane associated proteins which export tetracycline from the cell, and reduces the 
intracellular drug concentration protecting the ribosomes inside the cell; some of these genes are 
tet(P), tetA(P) and otr(C) (Chopra & Roberts, 2001). Other tet genes like tet(M), tet(O), tetP(B), 
tet(Q), tet(S), tet(T), tet(W) and otr(A), which protects the ribosome of the bacterial from binding 
to the antibiotic tetracycline. The presence of tet and otr genes with efflux or ribosomal protection 
mechanisms of resistance is similar with the hypothesis of lateral gene transfer from the 
tetracycline producing Streptomycetes to other bacteria  (Chopra & Roberts, 2001).  
Fosfomycin resistance mechanisms described in Escherichia coli include target modification of 
the gene murA, expression of enzymes which degradate the antibiotic, reduce uptake, and 
rescue of the biogenesis pathway of “UDP-MurNAc“ which is a pentapeptide of l-alanine ligase 
and alanyl-tRNA synthetase genes overexpressed in Escherichia coli (Bouhss, et al., 2001). FosA 
a glutathione S-transferase causes enzymatic resistance to fosfomycin and several Escherichia 
coli lineages carrying FosA  also produce ESBLs. Sequenced genes which are encode by 
glutathione S-transferase variants are fosA, fosA2, fosA3, fosA4, fosA5, and fosC2 (Benzerara, et 
al., 2017) (Alrowais, et al., 2015). 
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OBJECTIVE 
 
- Analyze the diversity of antimicrobial resistance genes found in Escherichia coli strains 
from the population of children and animal of Yaruqui-Centro, Quito Ecuador. 
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MATERIALS AND METHODS 
 
Time and study location 
 
Samples were collected from the community of Yaruqui Centro in Quito Ecuador during February 
to August 2015, fresh fecal samples from children from 0 to 5 years old (with informed consent 
from parents). Domestic animal fecal samples (approved by the Institute for Animal Care and Use 
Committee at the George Washington University (IACUC#A296)) were collected from the floor. 
Samples were transported to the USFQ Microbiology Laboratory immediately in a cooler at 4ºC; 
as soon as they arrived samples were cultured and stored frozen at -80ºC in 1.5 ml aliquots 
(Sarzosa, 2016). 
 
Microbiological Identification and isolation. 
 
Fecal samples (n=56) were cultured in MacConkey Agar, after 24h incubation at 37ºC were 
selected lactose fermenting colonies.  Antibiotic susceptibility test was carried out using Mueller 
Hinton for 24h incubation at 37ºC with the Kirby Bauer method following CLSI instructions 
(described in the next step). At the same time the susceptibility test was done, a biochemical 
reaction in different culture media for identification of bacteria was performed, to help identify by 
genera and specie the bacteria found in fecal samples: Escherichia coli, lately confirmed by DNA 
sequencing and MLST. 
 
Antibiotic Susceptibility Test. 
 
The antibiotic susceptibility of E. coli was measured using disk diffusion method assessed by 
Kirby-Bauer method according to Clinical and Laboratory Standards Institute (CLSI 2016). 12 
different antibiotic disks vials were used: Amoxicillin-Clavulanic acid [AMC], Ampicillin [AM], 
Streptomycin [S], Gentamicin [CN], Trimethoprim-sulfamethoxazole [SXT], Ciprofloxacin [CIP], 
Chloramphenicol [C], Cephalothin [KF], Cefotaxime [CTX], Tetracycline [TE], Sulfisoxazole [G] 
and Imipenem [IPM]. The interpretive criteria or cut-off values to determine susceptible or 
resistance strains were determined by the measurement of diameters of the halos and the 
interpretation was taken from CLSI 2016 guidelines (CLSI, 2016). 
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Mutant Selection  
 
For the selection of transconjugants, we selected a mutant strain from E. coli One Shot™ TOP10 
(lac-, StrepR) Invitrogen (Carlsbad, USA). One Shot™ TOP10 E. coli was inoculated in 100 ml of 
Brain Heart Infusion BHI liquid media and incubated at 37°C for 24h.  After 24 hours  another 100 
mls of BHI liquid media containing 50 ug/ml of Nalidixic Acid [NA] to reach a final concentration of 
25 ug/ml was added to the culture and incubated with no bacteria  at 37ºC for 24h. After 
incubation, the volume of BHI with 50 ug/ml of Nalidixic Acid was added to the culture media with 
One Shot™ TOP10 E. coli. The mixture was incubated at 37°C for additional 24h. Later, 200 μL 
of the mixture was transferred to a MacConkey Lactose Agar plate with 25 ug/ml of Nalidixic Acid, 
and incubated at 37°C for 24h.  A colony was selected and named Ec10NaR. 
The same procedure was repeated to select another mutant strain but Rifampicin resistant with 
One Shot™ TOP10 E. coli. A second mutant was selected and named: Ec10RaR (Segovia 
Limaico, 2008). 
 
Conjugation. 
Eighteen strains (16 human isolates and 2 animal isolates) were selected for their similar 
resistance pattern and were subjected to  conjugation with One shot TOP 10 Escherichia coli, or 
any of the mutants Ec10NaR or Ec10RaR, depending to the antibiotics that they were susceptible 
or resistant. The process of conjugation in which a donor cell (Yaruquí E. coli strains) transfer 
resistance plasmids to a recipient cell (One shot TOP 10 Escherichia coli, Ec10NaR, Ec10RaR) 
was done by mixing in a proportion of 1:1 of a 10 mL tube of Tryptic Soy Broth liquid medium with 
a donor inoculated bacteria from Yaruquí strains with 10 mL tube of Tryptic Soy Broth liquid 
medium with a recipient inoculated bacteria (One shot TOP 10 Escherichia coli, Ec10NaR, 
Ec10RaR) both previously incubated at 37ºC for 24h. Transconjugants were selected transferring 
200 μL of the mixture to a MacConkey agar plate which had a concentration of antibiotics like: 
streptomycin, tetracycline, nalidixic acid, rifampicin, cephalothin, depending which recipient we 
chose. Antimicrobial susceptibility of transconjugants was confirmed in Mueller Hinton using disk 
diffusion method by Kirby-Bauer and according Clinical and Laboratory Standards Institute (CLSI 
2016). 
Replicon typing analysis of the transconjugated. 
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The 18 selected strains that were conjugated resulted in 18 transconjugated strains that were 
used to analyze by the replicon using PBRT kit DIATHEVA (Fano PU, Italy) 
(https://www.diatheva.com).  Bateria were grown  in MacConkey media to confirm the Lactose 
negative pattern. And 3 to 5 strains were selected for DNA extraction using DNAzole 
ThermoFisher Scientific (Carlsbad, USA). 2 μL of the extracted DNA or positive controls and 
negative controls (E. coli K12 with no antibiotic resistance) were taken to the mix reaction. 
Replicons were amplified  using of 28 primers, each of them represent an especific amplicon 
length (bp), performed by 8 multiplex. For each PCR master mix, there were added 23,8 μL of the 
mix solution plus 0,2 μL of DNA polymerase Invitrogen (Carlsbad, USA); each PCR mix solution 
of 600 μL included specific levels of primers, dNTPs, Mg+2, PCR water non specified by the 
manufacturer because it was a pre-fabricated kit. The PCR parameters were: 1 cycle of 95°C for 
10min; 25-30 cycles of: 95°C for 60sec, 60°C for 30sec, 72°C for 60sec; and last 1 cycle of 72°C 
for 5min. It was cooled down to 4°C. The final volume of the reaction was 26 μL. 
We detected 25 replicons: HI1, HI2, I1, I2, X1, X2, L/M, N, FIA, FIB, FIC, FII, FIIS, FIIK, W, Y, P, 
A/C, T, K, U, R, B/O, HIB-M and FIB-M, which are the most representative of a major plasmid 
incompatibility groups and replicase genes which were identified on resistance plasmids 
circulating among Enterobacteriaceae; positive controls for each multiplex were also included in 
every reaction. PCR reaction was perfomed following specifications described by (Carattoli, et al., 
2005).  
Later, the amplified products of the multiplex (5 μL) were separated by electrophoresis with 
agarose gel 2.5% using ethidium bromide and a DNA standar specific ladder of low range (100-
1000 bp). The PCR products obtained were run in the gel as long as all amplicons had generated 
(aproximately 35 min), visualized under the transilluminator of UV.  
DNA extraction and whole genome sequencing. 
A subset of 8 strains isolated from Yaruquí in 2005 were subjected to DNA extraction using  
DNeasy Blood & Tissue of the QIAGEN (Texas, USA) and plasmid DNA was obtained from 
corresponding transconjugants using Plasmid QIAprep Spin Miniprep QIAGEN (Texas, USA) in 
both cases we followed instructions from the manufacturer. The chromosomic and plasmid DNA 
were sent to University of Minnesota, Saint Paul Office: 1971 Commonwealth Ave., 205 
Veterinary Science Saint Paul, MN 55108, USA. DNA sequences were obtained using Illumina 
miSeq. Paired reads were assembled using Velvet 1.2.1, genes were annotated using Patric 
3.4.12, MLST of total genome sequences bacteria was performed in the Center for Genomic 
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Epidemiology server according to: (Larsen, et al., 2012) PlasmidFinder and pMLST was 
performed in the Center for Genomic Epidemiology server according to: (Carattoli, et al., 2014) 
Antimicrobial Resistance genes finder was performed in the Center of Genomic Epidemiology 
server based on the parameter of ResFinder 3.0 which identifies acquired antimicrobial 
resistance genes but also chromosomal mutations in total or partial sequenced isolates of 
bacteria (Zankari, et al., 2012). 
Data Analysis. 
Chi square test was performed using IBM SPSS Statistic 20. For tables and graphs Microsoft 
Office Excel 2010 (Redmond, WA, USA) 
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RESULTS  
 
Participants. 
 
From the 56 strains that were obtained 44 (78,6%) of them corresponded to bacteria isolated 
from human feces (children), while the remaining 12 (21,4%) corresponded to bacterial isolated 
from domestic animal feces; 12 of the isolated strains from domestic animal feces of the 
community of Yaruquí: 7 (12%) belonged to Canis lupus familiaris (dog), 2 (4%) to Gallus gallus 
domesticus (rooster), 1 (2%) to Felis silvestrus catus (cat), 1 (2%) to Ovis orientalis aries (sheep) 
and the last one corresponded to 1 (2%) Anser anser domesticus (Goose).                        
 
Antibiotic resistance profiles 
 
The 56 strains showed resistance to: Amoxicillin - Clavulanic acid [AMC], 21 (37,5%), Ampicillin 
[AM], 26 (46,4%); Streptomycin [S], 18 (32,1%); Gentamicin [CN], 7 (12,5%); Trimethoprim-
sulfamethoxazole [SXT], 22 (39,3%); Ciprofloxacin [CIP],  3 (5,4%); Chloramphenicol [C], 5 
(8,9%); Cephalothin [KF], 31 (55,4%); Cefotaxime [CTX], 7 (12,5%); Tetracycline [TE],   33 
(58,9%) and  Sulfisoxazole [G],  26 (46,4%).  
Eighteen isolates had similar pattern of resistance: ampicillin, trimethoprim-sulfamethoxazole, 
cephalotin, tetracycline and sulfisoxazole, 16 of them corresponded to isolates from children and 
2 corresponded to isolates from domestic animals (1 dog and 1 goose).  
The transconjugates from the 18 strains showed a resistance pattern to ampicillin, trimethoprim-
sulfamethoxazole, cephalotin and tetracycline and in fewer cases resistance to gentamicin and 
cefotaxime. (Appendix 1) 
The rate of resistance in E. coli from human and domestic animals was different for all antibiotics: 
Resistance to amoxicillin - clavulanic acid was 38,6% for human and 33,3% for animals isolates; 
streptomycin  36,4% in human and 16,7% in animals isolates; gentamicin 13,6% for humans and 
8,3% in animals isolates; trimethoprim-sulfamethoxazole 40,9% for humans and 33,3% for 
animals isolates; ciprofloxacin 6,8% for humans and there were no percentage of resistance in 
animals isolates; chloramphenicol 6,8% for humans  and higher percentage was showed in 
animals isolates with 16,7%; cephalotin 52,3% for humans and  66,7% in animal isolates; 
cefotaxime 13,6% for humans  and a lower percentage in animals isolates with 8,3%; tetracycline 
61,4% for humans and  50,0% for animal isolates; sulfisoxazole 50,0% for humans and  33,3% 
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for animals isolates. The difference in the resistance patterns found in human and animal strains 
had no statistical significance (p>0.05) (Table 2)  
Isolates obtained from children showed more resistance to Tetracycline (61,4%) followed by 
Cephalothin (52,3%) and Ampicillin (52,3%). The highest percentages of resistance in isolates 
obtained from animals were Cephalothin (66,7%) and Tetracycline (50,0%).  The most frequent 
pattern of antibiotic resistance profile is:  resistance to tetracycline, sulfisoxazole, ampicillin, 
streptomycin, trimethoprim-sulfamethoxazole and cephalothin; the majority of these isolates 
belonged to humans. (Table 2) 
The dog and the goose cohabitated on the same household, shared some resistance pattern to: 
amoxicillin / clavulanic acid, ampicillin, streptomycin, cephalothin, trimethoprim sulfamethoxazole, 
tetracycline and sulfisoxazole, except in the antibiotic chloramphenicol, gentamicin and 
cefotaxime which was presented only in the dog. The fact that the dog and the goose belonged to 
the same household has no statistical significance in contrast to the shared antibiotic resistance 
genes.  
 Genotyping 
Based on the mutilocus sequence typing (MLST) from eight of the fifty six samples, with the 
combination of the genes: adk, fumC, gyrB, icd, mdh, purA and recA, we conclude that each of 
the eight sequenced samples have a different sequence type (ST): 941, 1485, Unknown1, 
Unknown2, 117, 5019, 120 and Unknown3.  
Plasmid Genotyping 
Plasmid replicons from transconjugants showed the same type of antibiotic resistance profiles as 
the donor strains; replicons were: HI1, I1γ, I2, FIIK, FII, X3, X2, FIB, P, I1α, N, FIIS, FIC, K, FIA, 
R (Table 4). The most common replicons were FII found in all of the sequenced samples except 
one, and I1γ was found in most of the samples but two (Table 3). Some replicons found only in 
human strains: FIIK, FIB, P, FIA, R; others only in domestic animal strains: N. In both types of 
animals and humans transconjugated strains the replicons found were: I1α, K, X2, FII, HI1, X3, 
I1γ, FIIS and FIC. (Fig 1) Results of pMLST of donor strains showed that FII18 was present in 
the majority of the samples except 2. These pMLSTs were found only in human strains: FII1, 
FIA13, FIB31, FIA5, FII2, FIB10, FIB26, and FIB20. In both animals and human strains it was 
found: pMLSTs: FII18, FIB1, and FIA6. (Fig 2) The results of pMLST showed that one of the 
plasmids FII18 is in the majority of the samples except two of them. (Table 4) The most prevalent 
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plasmids FIB1 and FIA6 were found in four of eight sequenced samples. (Appendix 1) We also 
found plasmids in unique isolates obtained in the pMLST which are:  FII11, FIA13, FIB31, FIA5, 
FIB10, FIB26, and FIB20. (Appendix 1) 
Analysis of Antibiotic resistance genes 
The strains that had a similar resistance pattern like: ampicillin, streptomycin, 
trimethoprim/sulfamethoxazole, cephalothin, tetracyclin and sulfisoxazole belonged to 2 isolates 
from humans that live in different houses of Yaruqui´s community. These strains shared some 
plasmids sequenced from WGS which type is IncFIB (AP001918), and resistant genes like bla-
TEM-1B, qnrB19, strA, strB, sul2. (Appendix 1)  
Most isolates shared resistance gene blaTEM-1B which causes resistance to beta lactams,  
The next most shared genes are: strA, strB which causes resistance to streptomycin. (Appendix 
1) Sul 2 gene is in five of eight strains and Sul 1 associated with resistance to Sulfisoxazole and 
sulfamethoxazole. (Appendix 1) 
The gene cepA which belongs to a human and present a resistance pattern for Cefotaxime that 
confirm the ability of this gene to give resistance to cephalosporin up to fourth generation 
because of the presence of the enzyme Extended Spectrum Beta Lactamase (ESBL). (Table 5) 
A phylogenetic tree was done by Mega (Maximum Likelihood) with the most repeated genes and 
showed that all of the compared sequences were identical or similar without nucleic bases that 
differ from each other. (Figure 4-9) 
Plasmid and Antibiotic resistance profile 
Not all the strains that had been sequenced have the same plasmids, the plasmid which is the 
most repeated identified by WGS are: IncFIB(AP001918) in all of the strains except one sample 
from a human isolate, followed by IncFII present in four samples from eight of the total. (Appendix 
1) 
Different isolates IncFIB(AP001918), IncFII, IncI2, IncFIC(FII), IncQ1, IncFIB(K),  IncFII(Yp), 
IncR, ColRNAI, Col(MP18), Col156, IncFII(pHN7A8), IncI1, IncN, IncFIA, IncFII(pRSB107), 
IncX4, Col(MG828), Col(BS512) seemed  associated with different Antibiotic Resistance patterns 
(Appendix 1). 
The transconjugates of the isolates carrying these plasmids showed different and uncomplete 
resistance this could explain that there is not only one plasmid which is transmitted.  
27 
 
Antibiotic resistance genes found in humans and animals 
 
The antibiotic resistance genes found only in human isolates were: dfrA8, dfrA17, dfrA18, strA, 
tet(B), dfrA7, dfrA14, cepA, mph(A), tet(Q), aac(3)-Iid, blaCTX-M-3, aadA5,  the antibiotic 
resistance genes found only in animals were blaACT-14, aadA2, aac(3)-Via, aadA1, blaCTX-M-
55, cmlA1, dfrA1, floR, sul3. And antibiotic resistance genes found in both were blaTEM-1B, 
qnrB19, strB, sul2, tet(A), fosA, sul1. (Table 5) (Fig 3) Between the results of antibiotic resistance 
in humans and animals from Yaruquí Centro there was no statistical significance. (p>0.05). In the 
replicon typing assay, a statistical significance was found in the replicon “N” with a p value of 
0.004, only present in animals. Also a statistical significance was found in the presence of the 
gene fosA with a P value of 0.04 present in 1 human and the two studied animals.  
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DISCUSSION 
In this study we atempted to determine the potential transfer of antibiotic resistance genes from domestic 
animals to humans. Based on the mutilocus sequence typing (MLST) we conclude that none of the 
individuals sampled in this study was colonized by the same antibiotic resistance E. coli clone (Appendix 
1). The scientific literature indicate that there is a potential spread of antibiotic resistant clones between 
humans and animals, and this could happen because of direct contact with animals or ingestion of 
contaminated food (Alonso, et al., 2017). The uncontrolled use of antibiotics in poultry and livestock 
production, and animal’s fecal management systems as well as close contact with animal may favor the 
selection of antimicrobial‐resistant bacteria and transmission from domestic animals to humans (Alonso, et 
al., 2017). Additionally, international livestock and derived meat trade is leading to an emergence in the 
dissemination of resistant strains and genetic determinants. Resistance to antimicrobial families is co‐
selected and disseminated not only by clonal spread but also horizontally via plasmids carrying genes 
(Alonso, et al., 2017). 
 
The presence of these allelic variants of antibiotic resistance resistance genes  blaTEM-1B, qnrB19, strB, 
sul2, tet(A), fosA, sul1 in E. coli from domestic animals and humans suggests potential  migration of these 
genes between domestic animals and humans. The antibiotic resistance genes found only in human 
isolates were: dfrA8, dfrA17, dfrA18, strA, tet(B), dfrA7, dfrA14, cepA, mph(A), tet(Q), aac(3)-Iid, blaCTX-
M-3, aadA5. The antibiotic resistance genes found only in animals were blaACT-14, aadA2, aac(3)-Via, 
aadA1, blaCTX-M-55, cmlA1, dfrA1, floR, sul3. There were no statistically significant differences in 
resistance genes or phenotypic resistrance between isolates from domestic animals and humans.   Our 
results are in agreement with previous reports showing evidence of horizontal gene transfer between 
bacteria in domestic animals and bacteria in humans (Sheppard, et al., 2016 ).  
Replicon typing analysis and plasmid sequencing suggested that several distinct plasmids carrying 
different assortment of replicons and antibiotic resistance genes circulate in this community and the most 
common replicons found in bacteria from domestic animals and humans were I1α, K, X2, FII, HI1, X3, I1γ, 
FIIS and FIC. The results of pMLST present in animals and humans were: FII18, FIB1, and FIA6, which 
could also suggest migration of plasmid by horizontal transfer between human and domestic animal strains 
and vice versa. The most prevalent replicon which was able to conjugate was FII with 87.5% and FIB with 
62.5%. While the most prevalent replicon in  bacteria from domestic animals was X2 and also FII 
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representing the 50% of the animal cases. Also no statistically significant (p value >0.05)   showed 
association of replicons with either  domestic animals and humans. The replicon “N” was found only in E. 
coli from domestic animals, but these observations were not statistically significant (p=0.54), however this 
lack of statistic association may be due to low number of animal isolates. The presence of similar replicons 
in human and animal bacteria suggests the transmition of plasmids between species.   
 
E. coli from chickens in Colombia showed various incompatibility groups : IncI1, IncK, IncF, IncHI2, IncA/C 
and IncΒ/O and harboured ESBL/AmpC genes. However, they also showed  association of blaCMY-2 and 
blaSHV-12 with IncI1 plasmids (Castellanos, et al., 2017). The features associated to replicon typing, 
plasmids, STs and its interactions with E. coli hosts are of further interest to assess the factors influencing 
the successful spread of resistance genes between domestic animals and humans. In a minireview by 
Carattoli in 2009 showed that in Perú the presence of the enzyme CTX-M2 is associated with the replicon 
A/C, FVII, NT, found in E. coli isolates from human sources, also the enzyme CTX-M-14 with the replicon I1 
found in E. coli and other enzymes like CTX-M-15 with the most common replicons FII, FIA, FIB. The gene 
CTX-M-24 with the replicon I1 and CTX-M-56 with the replicon A/C (Carattoli A., 2009). Interestingly, CTX-
M-14 gene which is a member of the linage of ESBLs a CTX-M-type β-lactamases had exhibited a dramatic 
dissemination in the past decade and with a difference in a sinlge nucleotide mutation is similar to CTX-M-2 
found also in Bolivia which suggest an evolution of resistance in local regions of Latin America (Pallecchi , 
et al., 2007).  Also Carattoli supported the evidence of the rapid dissemination of genetically unrelated E. 
coli which produced CTX-M-14, with the blaCTX-M-14 gene related with a common plasmid from the IncK 
group observed in human E. coli isolates found in Spain and France, suggesting an epidemic diffusion in 
Europe (Carattoli A. , et al., 2009). 
 
As a conclusion we can say that horizontal transfer of antibiotic resistance genes between bacteria in 
domestic animals and bacteria in humans is probably occurring, however crosscolonization of antibiotic 
resistant E. coli strains is probably less common (in the community of Yaruquí).  
Most of the antibiotic resistance genes were transferred by conjugation (in vitro experiments)  which may 
suggest that conjugation is an important mechanism of horizontal transfer of antibitic resistant genes.In 
most of the cases the resistance antibiotica fenotype pattern coincide with the gene present in the bacteria 
genotype.   
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Table 1. Antibiotic Resistance prevalence in the population 
Origin Number 
of 
samples 
Number of Isolates Resistant to Antibiotics (%) 
AMC AM S CN SXT CIP C CF CTX TE G IPM 
Human 44 17 
(38,6) 
23 
(52,3) 
16 
(36,4) 
6 
(13,6) 
18 
(40,9) 
3 
(6,8) 
3 
(6,8) 
23 
(52,3) 
6 
(13,6) 
27 
(61,4) 
22 
(50,0) 
0 (0) 
Domestic 
animals 
12 4 
(33,3) 
3 
(25,0) 
2 
(16,7) 
1  
(8,3) 
4 
(33,3) 
0  
(0) 
2 
(16,7) 
8 
(66,7)  
1  
(8,3) 
6 
(50,0) 
4 
(33,3)  
0 (0) 
Total of 
Samples 
56 21 
(37,5) 
26 
(46,4) 
18 
(32,1) 
7 
(12,5) 
22 
(39,3) 
3 
(5,4) 
5 
(8,9) 
31 
(55,4) 
7 
(12,5) 
33 
(58,9) 
26 
(46,4) 
0 (0) 
 
 
Table 2. Antibiotic resistance in humans and animals from Yaruqui Centro 
Antibiotic Resistance Homo sapiens N (%)     Animal N (%) P value. 
X2 
Amoxicillin/clavulanic acid    
Resistance 17 (38,6) 4 (33,3) 0,74 
Ampicilin    
Resistance 23 (52,3) 3 (25) 0,09 
Streptomycin    
Resistance 16 (36,4) 2 (16,7) 0,2 
Gentamicin    
Resistance 6 (13,6) 1 (8,3) 0,62 
Trimethoprim/sulfamethoxazole    
Resistance 18 (40,9) 4 (33,3) 0,6 
Ciprofloxacin    
Resistance 3 (6,8) 0 0,35 
Chloramphenicol     
Resistance 3 (6,8) 2 (16,7) 0,29 
Cephalothin    
Resistance 23 (52,3) 8 (66,7) 0,37 
Cefotaxime    
Resistance 6 (13,6) 1 (8,3) 0,62 
Tetracycline    
Resistance 27 (61,4) 6 (50) 0,47 
Sulfisoxazole     
Resistance 22 (50) 4 (33,3) 0,31 
Imipenem    
Resistance 0 0 0 
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Table 3. Replicon typing of 18 transconjugants, 16 from Humans and 2 from Animals  
Replicon 
typing 
Homo sapiens  
N (%)      
Animal  
N (%)  
P value. 
X2 
HI1    
Present 1 (6.2) 1 (50.0) 0.06 
I1α    
Present 1 (6.2) 1 (50.0) 0.06 
I2    
Present 1 (6.2) 0 0.72 
N    
Present 0 1 (50.0) 0.004 
X3    
Present 2 (12.5) 1 (50.0) 0.18 
I1γ    
Present 8 (50.0) 1 (50.0) 1.00 
FIIS    
Present 8 (50.0) 1 (50.0) 1.00 
X2    
Present 8 (50.0) 2 (100.0) 0.18 
FIC    
Present 2 (12.5) 1 (50.0) 0.18 
K    
Present 3 (18.8) 1 (50.0) 0.32 
    
FII    
Present 14 (87.5) 2 (100) 0.60 
FIB    
Present 10 (62.5) 0 0.09 
P    
Present 4 (25.0) 0 0.42 
FIIK    
Present 2 (12.5) 0 0.60 
FIA    
Present 3 (18.8) 0 0.50 
R    
Present 2 (12.5) 0 0.60 
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Table 4. pMLST of the sequenced strains 
pMLST  Homo sapiens N (%)     Animal N (%) P value. 
X2 
FII11    
Present 1 (16.7) 0 0.54 
FIA13    
Present 1 (16.7) 0 0.54 
FIB31    
Present 1 (16.7) 0 0.54 
FII18    
Present 4 (66.7) 2 (100) 0.35 
FIA5    
Present 1 (16.7) 0 0.54 
FIB1    
Present 2 (33.3) 2 (100) 0.1 
FII2    
Present 1 (16.7) 0 0.54 
FIA6    
Present 3 (50.0) 1 (50.0) 1.00 
FIB10    
Present 1 (16.7) 0 0.54 
FIB20    
Present 1 (16.7) 0 0.54 
FIB26    
Present 1 (16.7) 0 0.54 
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Table 5. Resistance genes in humans and animals 
Resistance 
genes 
Homo sapiens N (%)     Animal N (%) P value. X2 
blaTEM-1B    
Present 5 (83.3) 2 (100) 0.54 
blaACT-14    
Present 0 1 (50.0) 0.06 
blaCTX-M-55    
Present 0 1 (50.0) 0.06 
blaCTX-M-3    
Present 1 (16.7) 0 0.54 
dfrA1    
Present 0 1 (50.0) 0.06 
dfrA7    
Present 2 (33.3) 0 0.35 
dfrA8    
Present 1 (16.7) 0 0.54 
dfrA14    
Present 1 (16.7) 0 0.54 
dfrA17    
Present 3 (50.0) 0 0.21 
dfrA18    
Present 1 (16.7) 0 0.54 
qnrB19    
Present 4 (66.7) 1 (50.0) 0.67 
strA    
Present 3 (50.0) 0 0.21 
strB    
Present 3 (50.0) 1 (50.0) 1.00 
sul1    
Present 2 (33.3) 1 (50.0) 0.67 
sul2    
Present 3 (50.0) 2 (100) 0.21 
sul3    
Present 0 1 (50.0) 0.06 
tet(A)    
Present 2 (33.3) 1 (50.0) 0.67 
tet(B)    
Present 2 (33.3) 0 0.35 
tet(Q)    
Present 1 (16.7) 0 0.54 
fosA    
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Present 1 (16.7) 2 (100) 0.04 
cepA    
Present 1 (16.7) 0 0.54 
mph(A)    
Present 4 (66.7) 0 0.1 
aadA1    
Present 0 1 (50.0) 0.06 
aadA2    
Present 0 1 (50.0) 0.06 
aadA5    
Present 1 (16.7) 0 0.54 
aac(3)-Via    
Present 0 1 (50.0) 0.06 
aac(3)-lid    
Present 2 (33.3) 0 0.35 
cmlA1    
Present 0 1 (50.0) 0.06 
floR    
Present 0 1 (50.0) 0.06 
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Figure 1. Venn´s Diagram: Results of the analysis of replicon typing showing prevalence in human and 
animal strains separately and some shared replicons between them. 
 
Figure 2. Venn´s Diagram: Results of pMLST found in strains of humans and animals 
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 Figure 3. Venn´s Diagram: gene resistance in strains of humans and animals 
 
 
 
Figure 4. Phylogenetic tree: (Maximum Likelyhood) of the gene strA found in 3 different human strains. 
Bootstrap <9. 
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Figure 5. Phylogenetic tree (Maximum Likelyhood) of the gene blaTEM-1B found in 7 different strains: 2 
belong to animals (a goose and a dog), and the rest from human isolates. Bootstrap value 11. 
 
 
 
 
 
Figure 6. Phylogenetic tree: (Maximum Likelyhood) of the gene dfrA17 found in 4 different strains which 
belonged to humans isolates. Bootstrap < 9 
 
 
 
 
 
 
Figure 7. Phylogenetic tree: (Maximum Likelyhood) of the gene strB found in 4 different strains, three 
belong to human isolates and one from animal. Bootstrap < 9 
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Figure 8. Phylogenetic tree (Maximum Likelyhood) of the gene sul2 found in 5 different strains: 3 belonged 
to human isolates and 2 from animal. Bootstrap value 20. 
 
 
 
Figure 9. Phylogenetic tree (Maximum Likelyhood) of the gene QnrB19 found in 5 different strains, which 
belonged from human isolates. Bootstrap value 20. 
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Appendix 1. Recompilation of the information of the study 
  Nº 
Isolate 
ID 
Origin ST WGS 
Antibiotic 
Resistance profile 
Plasmid 
Transconjugated 
Replicons  
pMLST 
Transconjugate 
Antibiotic 
Resistance 
profile 
Antibiotic resistance 
genes 
1 8 8,5 Homo sapiens ND ND 
AM, S, SXT, C, CF, 
TE, G 
ND FIB, FIA, FIIS, FII ND ND ND 
2 26 26,1 
Felis silvestris 
catus 
ND ND CF ND ND ND ND ND 
3 32 32,1 
Ovis orientalis 
aries 
ND ND AM, TE ND ND ND ND ND 
4 35 35,1 
Gallus gallus 
domesticus 
ND ND SXT, TE ND ND ND ND ND 
5 46 46,1 Homo sapiens ND ND AM, S, SXT, TE, G  ND ND ND ND ND 
6 54 54,5 Homo sapiens 941 No clone 
AM, S, SXT, CF, TE, 
G 
IncFIB(AP001918), 
IncFII, IncI2 
HI1, X3, I1γ, FIIK, FII 
FII11, FIA13, 
FIB31 
AM, SXT, CF, 
TE 
blaTEM-1B, dfrA8, dfrA17, 
dfrA18, qnrB19, strA, strB, 
sul2, tet(B) 
7 74 74,1 Homo sapiens ND ND SXT,TE ND ND ND ND ND 
8 76 76,1 Homo sapiens ND ND NONE ND ND ND ND ND 
9 77 77,4 Homo sapiens ND ND NONE ND ND ND ND ND 
10 78 78,3 Homo sapiens ND ND AM, S, SXT, G ND ND ND ND ND 
11 79 79,1 
Canis lupus 
familiaris 
ND ND NONE ND ND ND ND ND 
12 80 80,4 Homo sapiens 1485 No clone 
AM, S, SXT, CF, TE, 
G 
IncFIB(AP001918), 
IncFIC(FII), IncQ1 
X3, I1γ, FIIK 
FII18, FIA5, 
FIB1 
AM, SXT, CF, 
TE 
blaTEM-1B, dfrA7, dfrA14, 
qnrB19, strA, strB, sul2, 
tet(A) 
13 81 81,2 
Canis lupus 
familiaris 
ND ND NONE ND ND ND ND ND 
14 82 82,3 Homo sapiens ND ND TE ND ND ND ND ND 
15 87 87,1 Goose Unknown1 No clone 
AMC, AM, S, SXT, 
CF, TE, G 
IncFIB(AP001918), 
IncFIB(K), IncFII, 
IncFII(Yp), IncR 
X2, FII 
FII18, FIA6, 
FIB1 
AM, SXT, CF, 
TE 
blaACT-14, blaTEM-1B, 
fosA, qnrB19, strB, sul2 
16 88 88,1 Homo sapiens ND ND TE ND ND ND ND ND 
17 89 89,1 Homo sapiens ND ND CF ND ND ND ND ND 
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18 90 90,1 Homo sapiens ND ND 
AMC, AM, S, SXT, 
CF, TE, G 
ND FIIS, X2, FIC, K, FII ND ND ND 
19 91 91,1 Homo sapiens Unknown2 No clone 
AMC, AM, S. SXT, 
CF, CTX,TE, G 
IncFII, ColRNAI, 
Col(MP18), Col156 
FIB, P, I1γ, X2, FII FII2, FIB10 
AM, SXT, CF, 
CTX, TE 
cepA, dfrA17, mph(A), 
tet(Q) 
20 92 92,2 
Canis lupus 
familiaris 
117 No clone 
AMC, AM, S, CN, 
SXT, C, CF, CTX, TE, 
G 
IncFIB(AP001918), 
IncFII(pHN7A8), 
IncFIC(FII), IncI1, 
IncN, ColRNAI 
HI1, I1α, N, X3, I1γ, 
FIIS, X2, FIC, K, FII 
FII18, FIB1 
AM, CN, SXT, 
CF, CTX, TE 
aadA2, aac(3)-Via, 
aadA1, blaTEM-1B, 
blaCTX-M-55, cmlA1, 
dfrA1, floR, fosA, sul1, 
sul2, sul3, tet(A) 
21 93 93,4 Homo sapiens ND ND 
AMC, AM, S, SXT, 
CF, TE, G 
ND X2, FII ND ND ND 
22 95 95,2 
Canis lupus 
familiaris 
ND ND AMC, CF ND ND ND ND ND 
23 96 96,2 Homo sapiens ND ND AMC, CF ND ND ND ND ND 
24 97 97,1 
Canis lupus 
familiaris 
ND ND SXT, CF, TE, G ND ND ND ND ND 
25 98 98,2 Homo sapiens ND ND NONE ND ND ND ND ND 
26 99 99,4 Homo sapiens ND ND AMC, CF ND ND ND ND ND 
27 100 100,1 Homo sapiens ND ND AMC, CF, TE ND ND ND ND ND 
28 101 101,3 Homo sapiens ND ND 
AMC, AM, S, SXT, 
CF, G 
ND 
I1α, I2, I1γ, FIIS, R, 
X2, FII 
ND ND ND 
29 103 103,2 
Gallus gallus 
domesticus 
ND ND CF, TE ND ND ND ND ND 
30 104 104,2 Homo sapiens ND ND AMC, AM, G ND ND ND ND ND 
31 105 105,4 
Canis lupus 
familiaris 
ND ND AMC, C, CF, G ND ND ND ND ND 
32 106 106,1 Homo sapiens 5019 No clone 
AMC, AM, S, CN, 
CIP, CF, CTX, TE 
IncFIB(AP001918), 
IncFIC(FII), IncI1 
FIB, P, I1γ, FIIS, X2, 
FIC, FII 
FII18, FIA6, 
FIB1 
AM, CN, CF, 
CTX, TE 
aac(3)-Iid, blaTEM-1B, 
blaCTX-M-3, fosA, 
mph(A), qnrB19, tet(A) 
33 107 107,5 Homo sapiens ND ND AMC, AM, SXT, TE, G ND ND ND ND ND 
34 108 108,2 Homo sapiens ND ND AMC ND ND ND ND ND 
35 109 109,2 Homo sapiens 120 No clone 
AMC, AM, S, CN, 
SXT, CF, CTX, TE, G 
IncFIB(AP001918), 
IncFIA, IncFIC(FII), 
IncI1 
FIB, FIA, I1γ, FIIS, R, 
FII 
FII18, FIA6, 
FIB26 
AM, SXT, CF, 
CTX, TE 
aac(3)-Iid, aadA5, 
blaTEM-1B, dfrA17, 
mph(A), qnrB19, sul1 
36 110 110,2 Homo sapiens ND ND AMC, AM ND ND ND ND ND 
37 111 111,1 Homo sapiens ND ND 
AMC, AM, S, SXT, C, 
CF, TE, G 
ND FIB, P, FII ND ND ND 
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38 112 112,5 Homo sapiens ND ND AMC, CF, TE ND ND ND ND ND 
39 113 113,4 Homo sapiens ND ND NONE ND ND ND ND ND 
40 114 114,1 Homo sapiens ND ND NONE ND ND ND ND ND 
41 115 115,2 Homo sapiens ND ND CF ND ND ND ND ND 
42 116 116,2 Homo sapiens ND ND AM, SXT, CF, TE, G ND FIB, FIIS, X2, K, FII ND ND ND 
43 117 117,2 Homo sapiens ND ND TE, G ND ND ND ND ND 
44 118 118,1 Homo sapiens Unknown3 No clone 
AMC, AM, S, CN, 
SXT, CIP, CF, CTX, 
TE, G 
IncFIB(AP001918), 
IncFII(pHN7A8), 
IncFII(pRSB107), 
IncFII, IncX4, 
Col(MG828), 
Col(BS512) 
FIB, FIIS, X2, FII 
FII18, FIA6, 
FIB20 
AM, CN, SXT, 
CF, CTX, TE 
blaTEM-1B, dfrA17, 
mph(A), strA, strB, sul1, 
sul2, tet(B) 
45 119 119,4 Homo sapiens ND ND NONE ND ND ND ND ND 
46 120 120,5 Homo sapiens ND ND AM, S, SXT, TE, G  ND ND ND ND ND 
47 130 130,2 Homo sapiens ND ND 
AM, S, SXT, CF, TE, 
G 
ND FIB, I1γ, FII ND ND ND 
48 131 131,2 Homo sapiens ND ND NONE ND ND ND ND ND 
49 132 132,3 
Canis lupus 
familiaris 
ND ND CF ND ND ND ND ND 
50 133 133,1 Homo sapiens ND ND TE ND ND ND ND ND 
51 134 134,2 Homo sapiens ND ND AM, C, TE, G ND ND ND ND ND 
52 135 135,5 Homo sapiens ND ND 
AMC, AM, CN, CF, 
TE, G  
ND P ND ND ND 
53 136 136,5 Homo sapiens ND ND TE ND ND ND ND ND 
54 139 139,4 Homo sapiens ND ND 
AM, CN, CIP, CF, 
CTX, TE, G 
ND FIB, FIIS, X2, K, FII ND ND ND 
55 141 141,2 Homo sapiens ND ND CF ND ND ND ND ND 
56 142 142,3 Homo sapiens ND ND 
AM, S, CN, SXT, 
CF,TE, G 
ND FIB, FIA, I1γ, FII ND ND ND 
 
